
Leigh C. Maier
Examiner (ID: 12110, Phone: (571)272-0656 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1614, 1621, 1693 |
| Total Applications | 1395 |
| Issued Applications | 727 |
| Pending Applications | 80 |
| Abandoned Applications | 594 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19027197
[patent_doc_number] => 11926544
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-03-12
[patent_title] => Biological desulfurizer for removing organic sulfur in fracturing flowback fluid and application thereof
[patent_app_type] => utility
[patent_app_number] => 18/487134
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 2990
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/487134 | Biological desulfurizer for removing organic sulfur in fracturing flowback fluid and application thereof | Oct 15, 2023 | Issued |
Array
(
[id] => 18825314
[patent_doc_number] => 11840584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Simple and green method for preparation of acid modified cyclodextrin
[patent_app_type] => utility
[patent_app_number] => 18/122181
[patent_app_country] => US
[patent_app_date] => 2023-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6415
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18122181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/122181 | Simple and green method for preparation of acid modified cyclodextrin | Mar 15, 2023 | Issued |
Array
(
[id] => 18497476
[patent_doc_number] => 20230220117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Biopolymers for Topical Use
[patent_app_type] => utility
[patent_app_number] => 18/183517
[patent_app_country] => US
[patent_app_date] => 2023-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18183517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/183517 | Biopolymers for topical use | Mar 13, 2023 | Issued |
Array
(
[id] => 19870415
[patent_doc_number] => 12263254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Composite materials
[patent_app_type] => utility
[patent_app_number] => 18/110262
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3063
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18110262
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/110262 | Composite materials | Feb 14, 2023 | Issued |
Array
(
[id] => 18270724
[patent_doc_number] => 20230091966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE WITH CYCLODEXTRINS
[patent_app_type] => utility
[patent_app_number] => 17/985762
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985762 | METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE WITH CYCLODEXTRINS | Nov 10, 2022 | Abandoned |
Array
(
[id] => 18565592
[patent_doc_number] => 20230255919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN
[patent_app_type] => utility
[patent_app_number] => 17/949970
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17949970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/949970 | COMPOSITION CONTAINING CYCLODEXTRIN AND BUSULFAN | Sep 20, 2022 | Abandoned |
Array
(
[id] => 18209545
[patent_doc_number] => 20230055805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TOLL-LIKE RECEPTOR LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/898165
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898165 | Toll-like receptor ligands | Aug 28, 2022 | Issued |
Array
(
[id] => 19151242
[patent_doc_number] => 11976139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Sodium hyaluronate with full molecular weight distribution (MWD), and preparation method and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/038777
[patent_app_country] => US
[patent_app_date] => 2022-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5654
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038777
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038777 | Sodium hyaluronate with full molecular weight distribution (MWD), and preparation method and use thereof | Jul 30, 2022 | Issued |
Array
(
[id] => 17981162
[patent_doc_number] => 20220347198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Treatment of Inflammatory Lesions of Rosacea with Ivermectin
[patent_app_type] => utility
[patent_app_number] => 17/811226
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811226 | Treatment of Inflammatory Lesions of Rosacea with Ivermectin | Jul 6, 2022 | Abandoned |
Array
(
[id] => 18194269
[patent_doc_number] => 20230047788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITIONS COMPRISING 5-CHOLESTEN-3, 25-DIOL, 3-SULFATE (25HC3S) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AT LEAST ONE CYCLIC OLIGOSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 17/852142
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17852142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/852142 | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide | Jun 27, 2022 | Issued |
Array
(
[id] => 19651321
[patent_doc_number] => 12173090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto
[patent_app_type] => utility
[patent_app_number] => 17/806323
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 21
[patent_no_of_words] => 26893
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806323 | Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto | Jun 9, 2022 | Issued |
Array
(
[id] => 19624158
[patent_doc_number] => 12162962
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture
[patent_app_type] => utility
[patent_app_number] => 17/836338
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12089
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836338 | Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture | Jun 8, 2022 | Issued |
Array
(
[id] => 18338117
[patent_doc_number] => 20230130066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => USE OF CYCLODEXTRINS IN DISEASES AND DISORDERS INVOLVING PHOSPHOLIPID DYSREGULATION
[patent_app_type] => utility
[patent_app_number] => 17/834133
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/834133 | USE OF CYCLODEXTRINS IN DISEASES AND DISORDERS INVOLVING PHOSPHOLIPID DYSREGULATION | Jun 6, 2022 | Abandoned |
Array
(
[id] => 18003517
[patent_doc_number] => 20220362283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => METHODS OF MANUFACTURING A HIGH MOLECULAR WEIGHT HEPARIN COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/743154
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743154 | Methods of manufacturing a high molecular weight heparin compound | May 11, 2022 | Issued |
Array
(
[id] => 19650013
[patent_doc_number] => 12171773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Inhibiting inflammation with milk oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 17/736468
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3349
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736468 | Inhibiting inflammation with milk oligosaccharides | May 3, 2022 | Issued |
Array
(
[id] => 18503661
[patent_doc_number] => 11701451
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-07-18
[patent_title] => Soft tissue filler and methods
[patent_app_type] => utility
[patent_app_number] => 17/692594
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 34
[patent_no_of_words] => 8605
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692594 | Soft tissue filler and methods | Mar 10, 2022 | Issued |
Array
(
[id] => 19777489
[patent_doc_number] => 12226510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Skin treatment methods and compositions with retinoid and delivery systems thereof
[patent_app_type] => utility
[patent_app_number] => 17/680816
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5605
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680816 | Skin treatment methods and compositions with retinoid and delivery systems thereof | Feb 24, 2022 | Issued |
Array
(
[id] => 17576921
[patent_doc_number] => 20220133776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => COMPOSITION INCLUDING GLUCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR
[patent_app_type] => utility
[patent_app_number] => 17/574761
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574761 | COMPOSITION INCLUDING GLUCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR | Jan 12, 2022 | Abandoned |
Array
(
[id] => 17625595
[patent_doc_number] => 20220160610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => EXOPOLYSACCHARIDE-PROTEIN COMPLEX, A METHOD OF PREPARING SAID COMPLEX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/570048
[patent_app_country] => US
[patent_app_date] => 2022-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7181
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570048
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570048 | EXOPOLYSACCHARIDE-PROTEIN COMPLEX, A METHOD OF PREPARING SAID COMPLEX AND USES THEREOF | Jan 5, 2022 | Abandoned |
Array
(
[id] => 19339299
[patent_doc_number] => 12049477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Azithromycin derivatives with epithelial barrier enhancement properties
[patent_app_type] => utility
[patent_app_number] => 17/551223
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14614
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551223
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551223 | Azithromycin derivatives with epithelial barrier enhancement properties | Dec 14, 2021 | Issued |